MedTrace Logo

A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis

NCT00930384 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2016-06-16

No results posted yet for this study

Summary

Main objectives

1\. Establish the association of psoriasis and the presence of NAFLD in the patients with psoriasis attending dermatologic clinic center.

Secondary objective

1. Evaluate for the presence of other components metabolic syndrome in this group of patients including hypercholesterolemia, hypertension, obesity, and insulin resistance
2. Determine if there is an association between the extent and severity of psoriasis and the presence of NAFLD.
3. Identify an association between BMI and presence of NAFLD in people with psoriasis and use it as a predictive index for primary screening of NAFLD in psoriatic patients.

Conditions

Sponsors & Collaborators

  • George Washington University

    lead OTHER

Principal Investigators

  • Alison Ehrlich, MD, MHS · GWU

  • Nadia Khati, MD · GWU

  • Monica Rengifo-Pardo · George Washington University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00930384 on ClinicalTrials.gov